ONTAK (denileukin diftitox) in patients with systemic mastocytosis.
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2012
At a glance
- Drugs Denileukin diftitox (Primary)
- Indications Leukaemia; Mastocytosis
- Focus Therapeutic Use
- 19 Jan 2012 Actual patient number (8) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual end date (1 Aug 2007 ) added as reported by ClinicalTrials.gov.
- 31 Aug 2007 Status change from in progress to completed